ArticleBlood2026

Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.

Bogdan Popescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.